Cargando…
Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661867/ https://www.ncbi.nlm.nih.gov/pubmed/33209905 http://dx.doi.org/10.21037/atm-20-3549 |
| _version_ | 1783609285084708864 |
|---|---|
| author | Alite, Fiori Mahadevan, Anand |
| author_facet | Alite, Fiori Mahadevan, Anand |
| author_sort | Alite, Fiori |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7661867 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76618672020-11-17 Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy? Alite, Fiori Mahadevan, Anand Ann Transl Med Editorial Commentary AME Publishing Company 2020-10 /pmc/articles/PMC7661867/ /pubmed/33209905 http://dx.doi.org/10.21037/atm-20-3549 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Alite, Fiori Mahadevan, Anand Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy? |
| title | Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy? |
| title_full | Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy? |
| title_fullStr | Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy? |
| title_full_unstemmed | Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy? |
| title_short | Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy? |
| title_sort | dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy? |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661867/ https://www.ncbi.nlm.nih.gov/pubmed/33209905 http://dx.doi.org/10.21037/atm-20-3549 |
| work_keys_str_mv | AT alitefiori doseescalationintheeraofablativelungirradiationismoredosebetterwhenitcomestodeliveryoflungstereotacticbodyradiationtherapy AT mahadevananand doseescalationintheeraofablativelungirradiationismoredosebetterwhenitcomestodeliveryoflungstereotacticbodyradiationtherapy |